The Enterprise Value as of December 2025 (TTM) for NKGen Biotech, Inc. Common Stock (NKGN) is 4.60M

According to NKGen Biotech, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 4.60M. This represents a change of -90.01% compared to the average of 46.08M of the last 4 quarters.

NKGen Biotech, Inc. Common Stock (NKGN) Historical Enterprise Value (quarterly & annually)

How has NKGN Enterprise Value performed in the past?

The mean historical Enterprise Value of NKGen Biotech, Inc. Common Stock over the last ten years is 97.43M. The current 4.60M Enterprise Value has changed 372.33% with respect to the historical average. Over the past ten years (40 quarters), NKGN's Enterprise Value was at its highest in in the December 2022 quarter at 134.41M. The Enterprise Value was at its lowest in in the December 2024 quarter at 18.89M.

NKGen Biotech, Inc. Common Stock (NKGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NKGen Biotech, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NKGen Biotech, Inc. Common Stock (NKGN) Average Enterprise Value

How has NKGN Enterprise Value performed in the past?

The current Enterprise Value of NKGen Biotech, Inc. Common Stock (NKGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NKGen Biotech, Inc. Common Stock (NKGN) Enterprise Value vs. Peers

How is NKGN’s Enterprise Value compared to its peers?

NKGen Biotech, Inc. Common Stock’s Enterprise Value is less than Windtree Therapeutics, Inc. (5.19M), greater than PMGC Holdings Inc. (-1178944.00), less than BriaCell Therapeutics Corp. Warrant (10.69M), greater than Protagenic Therapeutics, Inc. (3.67M), greater than XORTX Therapeutics Inc. (1.43M), less than Moolec Science S.A. (25.51M), greater than Virax Biolabs Group Limited (-1055720.00), greater than Dermata Therapeutics, Inc. (-2946603.00), less than Kadimastem Ltd (0), greater than Avenue Therapeutics, Inc. (-1162154.00),

Build a custom stock screener for NKGen Biotech, Inc. Common Stock (NKGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NKGen Biotech, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NKGen Biotech, Inc. Common Stock (NKGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NKGen Biotech, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.